ANDA 206572, held by Sciegen Pharms. Diflorasone Diacetate.
As of Nov 15, 2026, ANDA 206572 (Diflorasone Diacetate), held by Sciegen Pharms, was first approved by FDA on Jul 24, 2015, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jul 24, 2015 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Diflorasone Diacetate0.05% ยท ointment;topical | Diflorasone Diacetate | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
